- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Big Pharma Split Corp (PRM_pa)
Big Pharma Split Corp stock price live, this page displays TSX PRM_pa stock exchange data. View the PRM_pa premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Big Pharma Split Corp real time stock price chart below.
What Is the Big Pharma Split Corp Stock Price Today?
The Big Pharma Split Corp stock price today is 10.20.
What Is the Stock Symbol for Big Pharma Split Corp?
The stock symbol for Big Pharma Split Corp is ""PRM_pa.""
What Stock Exchange Does Big Pharma Split Corp Trade On?
Big Pharma Split Corp is listed and trades on the Toronto stock exchange.
Is Big Pharma Split Corp a Good Stock to Buy?
Determining whether Big Pharma Split Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PRM_pa quote. (ISIN: CA08934P2070)
What Is the Big Pharma Split Corp Stock Price Today?
The Big Pharma Split Corp stock price today is 10.20.
What Is the Stock Symbol for Big Pharma Split Corp?
The stock symbol for Big Pharma Split Corp is ""PRM_pa.""
What Stock Exchange Does Big Pharma Split Corp Trade On?
Big Pharma Split Corp is listed and trades on the Toronto stock exchange.
Is Big Pharma Split Corp a Good Stock to Buy?
Determining whether Big Pharma Split Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PRM_pa quote. (ISIN: CA08934P2070)
10.20
+0.06(+0.59%)
Closed·
Fair Value
An estimate of a Big Pharma Split's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.14
10.24
52 wk Range
9.83
10.69
PRM_pa Scorecard
Full Analysis
Pays a significant dividend to shareholders
High dividend Yield
1/2
Fair Value
An estimate of a Big Pharma Split's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.1410.24
52 wk Range
9.8310.69
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.90%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.90%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PRM_pa Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Big Pharma Split's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Short term obligations exceed liquid assets
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Big Pharma Split Corp Company Profile
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
Compare PRM_pa to Peers and Sector
Metrics to compare | PRM_pa | Sector Sector - Average of metrics from a broad group of related Financial sector companies | Relationship RelationshipPRM_paPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | 3.0x | 9.8x | |
PEG Ratio | - | −0.09 | 0.03 | |
Price/Book | 0.0x | 0.8x | 1.0x | |
Price / LTM Sales | 0.0x | 2.4x | 2.9x | |
Upside (Analyst Target) | - | 0.0% | 10.1% | |
Fair Value Upside | Unlock | 0.0% | 0.9% | Unlock |
Earnings
Latest Release
Mar 28, 2025
EPS / Forecast
-1.57 / --
Revenue / Forecast
231.54K / --
FAQ
What Stock Exchange Does Big Pharma Split Trade On?
Big Pharma Split is listed and trades on the Toronto Stock Exchange stock exchange.
What Is the Stock Symbol for Big Pharma Split?
The stock symbol for Big Pharma Split is "PRM_pa."
What Is the Big Pharma Split Market Cap?
As of today, Big Pharma Split market cap is 13.77M.
What Is Big Pharma Split's Earnings Per Share (TTM)?
The Big Pharma Split EPS (TTM) is -0.47.
From a Technical Analysis Perspective, Is PRM_pa a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Big Pharma Split Stock Split?
Big Pharma Split has split 0 times.
How Many Employees Does Big Pharma Split Have?
Big Pharma Split has 0 employees.
What is the current trading status of Big Pharma Split (PRM_pa)?
As of 29 Aug 2025, Big Pharma Split (PRM_pa) is trading at a price of 10.20, with a previous close of 10.20. The stock has fluctuated within a day range of 10.14 to 10.24, while its 52-week range spans from 9.83 to 10.69.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.